2nd Quarter - Report

PHILIPS HOLDING USA, INC. for PHILIPS HOLDING USA INC.

Firm
Client
Income
—
Expenses
$640,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2027 Veterans Affairs Appropriations, in general FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MATTHEW JOHN SHUMAN-TIMM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Veterans Affairs, Dept of (VA)

Veterans VET

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MATTHEW JOHN SHUMAN-TIMM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Defense DEF

S. 4784, FY27 National Defense Authorization Act (Sec. 804) and H.R. 8800, FY27 National Defense Authorization Act (Sec. 861, Sec. 862) Telehealth in DOD

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MATTHEW JOHN SHUMAN-TIMM —
MONICA VOLANTE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 4784 (119th), H.R. 8800 (119th)

Tariff (miscellaneous tariff bills) TAR

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
RICHARD PETER MERSKI —
ELIZABETH PIKA SHARP —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Council of Economic Advisers (CEA)

Taxation/Internal Revenue Code TAX

H.R. 1219, Oral Health Products Inclusion Act (whole bill)

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
RICHARD PETER MERSKI —
MONICA VOLANTE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1219 (119th)

Medicare/Medicaid MMM

S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill)

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
ELIZABETH PIKA SHARP —
MONICA VOLANTE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6197 (119th), H.R. 5343 (119th), S. 1399 (119th), S. 1717 (119th)

Health Issues HCR

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof S. 4519, the Medical Device Electronic Labeling Act (whole bill) and H.R. 1539, the Medical Device Electronic Labeling Act (whole bill)

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
ELIZABETH PIKA SHARP —
MONICA VOLANTE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Bills named: S. 4519 (119th), H.R. 1539 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.